A recent study explored a new way to treat certain patients with head and neck cancer. The researchers tested whether ...

Cancers occurring in the mouth, nose, and throat are on the rise in the U.S., especially in younger people. About 60,000 new ...

One of the youngest victims of proposed NIH funding cuts would be six-year-old Cailen Vela of Michigan, who has a rare and ...

Designation applies to the treatment of adult patients with recurrent or metastatic head and neck squamous cell carcinoma ...

The FDA accepted for priority review a supplemental Biologics License Application for Keytruda for resectable locally ...

Proton arc therapy offers a superior dose distribution compared with existing state-of-the-art proton delivery techniques ...

Merck & Co. has won U.S. Food and Drug Administration priority review for its application seeking expanded use of its blockbuster cancer drug Keytruda in certain patients with head and neck cancer.

A mother from Cannock who watched her identical twin boys go through tough cancer treatment - just weeks apart - has welcomed ...

Mean dose to the tongue mucosa did not improve predictions of taste impairment during and after radiation therapy compared ...

HPV causes irritating warts, or lesions, on the back, front, or side of the tongue. Males have a higher risk of developing ...

A headache lasting more than 72 hours must be addressed in the emergency room or with a doctor. Here's why it happens and the ...

Professor and surgeon Jason Hunt, MD, MS, FACS, has been named inaugural Chair of the Department of Otolaryngology – Head and ...